vs
Side-by-side financial comparison of FIRST INTERSTATE BANCSYSTEM INC (FIBK) and HAEMONETICS CORP (HAE). Click either name above to swap in a different company.
HAEMONETICS CORP is the larger business by last-quarter revenue ($339.0M vs $313.0M, roughly 1.1× FIRST INTERSTATE BANCSYSTEM INC). FIRST INTERSTATE BANCSYSTEM INC runs the higher net margin — 34.8% vs 13.2%, a 21.6% gap on every dollar of revenue. On growth, FIRST INTERSTATE BANCSYSTEM INC posted the faster year-over-year revenue change (19.8% vs -2.7%). Over the past eight quarters, FIRST INTERSTATE BANCSYSTEM INC's revenue compounded faster (13.7% CAGR vs 0.4%).
First Interstate BancSystem, Inc. is a financial holding company headquartered in Billings, Montana. It is the parent company of First Interstate Bank, a community bank with locations throughout 14 states within the Western and Midwestern United States. It is the largest bank based in Montana, as measured by total assets.
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
FIBK vs HAE — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $313.0M | $339.0M |
| Net Profit | $108.8M | $44.7M |
| Gross Margin | — | 59.7% |
| Operating Margin | 44.5% | 19.9% |
| Net Margin | 34.8% | 13.2% |
| Revenue YoY | 19.8% | -2.7% |
| Net Profit YoY | 108.8% | 19.3% |
| EPS (diluted) | $1.07 | $0.95 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $313.0M | $339.0M | ||
| Q3 25 | $250.5M | $327.3M | ||
| Q2 25 | $248.3M | $321.4M | ||
| Q1 25 | $247.0M | $330.6M | ||
| Q4 24 | $261.3M | $348.5M | ||
| Q3 24 | $251.9M | $345.5M | ||
| Q2 24 | $244.3M | $336.2M | ||
| Q1 24 | $242.2M | — |
| Q4 25 | $108.8M | $44.7M | ||
| Q3 25 | $71.4M | $38.7M | ||
| Q2 25 | $71.7M | $34.0M | ||
| Q1 25 | $50.2M | $58.0M | ||
| Q4 24 | $52.1M | $37.5M | ||
| Q3 24 | $55.5M | $33.8M | ||
| Q2 24 | $60.0M | $38.4M | ||
| Q1 24 | $58.4M | — |
| Q4 25 | — | 59.7% | ||
| Q3 25 | — | 59.5% | ||
| Q2 25 | — | 59.8% | ||
| Q1 25 | — | 58.4% | ||
| Q4 24 | — | 55.5% | ||
| Q3 24 | — | 54.2% | ||
| Q2 24 | — | 52.0% | ||
| Q1 24 | — | — |
| Q4 25 | 44.5% | 19.9% | ||
| Q3 25 | 37.0% | 17.9% | ||
| Q2 25 | 37.7% | 16.8% | ||
| Q1 25 | 26.9% | 21.6% | ||
| Q4 24 | 25.5% | 16.9% | ||
| Q3 24 | 28.9% | 15.0% | ||
| Q2 24 | 32.1% | 11.8% | ||
| Q1 24 | 31.7% | — |
| Q4 25 | 34.8% | 13.2% | ||
| Q3 25 | 28.5% | 11.8% | ||
| Q2 25 | 28.9% | 10.6% | ||
| Q1 25 | 20.3% | 17.5% | ||
| Q4 24 | 19.9% | 10.8% | ||
| Q3 24 | 22.0% | 9.8% | ||
| Q2 24 | 24.6% | 11.4% | ||
| Q1 24 | 24.1% | — |
| Q4 25 | $1.07 | $0.95 | ||
| Q3 25 | $0.69 | $0.81 | ||
| Q2 25 | $0.69 | $0.70 | ||
| Q1 25 | $0.49 | $1.17 | ||
| Q4 24 | $0.50 | $0.74 | ||
| Q3 24 | $0.54 | $0.66 | ||
| Q2 24 | $0.58 | $0.74 | ||
| Q1 24 | $0.57 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $363.4M |
| Total DebtLower is stronger | $146.3M | $1.2B |
| Stockholders' EquityBook value | $3.4B | $911.5M |
| Total Assets | $26.6B | $2.5B |
| Debt / EquityLower = less leverage | 0.04× | 1.34× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $363.4M | ||
| Q3 25 | — | $296.4M | ||
| Q2 25 | — | $292.9M | ||
| Q1 25 | — | $306.8M | ||
| Q4 24 | — | $320.8M | ||
| Q3 24 | — | $299.3M | ||
| Q2 24 | — | $344.4M | ||
| Q1 24 | — | — |
| Q4 25 | $146.3M | $1.2B | ||
| Q3 25 | $146.2M | $1.2B | ||
| Q2 25 | $252.0M | $1.2B | ||
| Q1 25 | — | $1.2B | ||
| Q4 24 | $132.2M | — | ||
| Q3 24 | $137.3M | — | ||
| Q2 24 | $383.4M | — | ||
| Q1 24 | $370.8M | — |
| Q4 25 | $3.4B | $911.5M | ||
| Q3 25 | $3.4B | $849.2M | ||
| Q2 25 | $3.4B | $882.3M | ||
| Q1 25 | $3.4B | $820.8M | ||
| Q4 24 | $3.3B | $906.9M | ||
| Q3 24 | $3.4B | $878.9M | ||
| Q2 24 | $3.2B | $905.4M | ||
| Q1 24 | $3.2B | — |
| Q4 25 | $26.6B | $2.5B | ||
| Q3 25 | $27.3B | $2.4B | ||
| Q2 25 | $27.6B | $2.5B | ||
| Q1 25 | $28.3B | $2.5B | ||
| Q4 24 | $29.1B | $2.5B | ||
| Q3 24 | $29.6B | $2.5B | ||
| Q2 24 | $30.3B | $2.5B | ||
| Q1 24 | $30.1B | — |
| Q4 25 | 0.04× | 1.34× | ||
| Q3 25 | 0.04× | 1.44× | ||
| Q2 25 | 0.07× | 1.39× | ||
| Q1 25 | — | 1.49× | ||
| Q4 24 | 0.04× | — | ||
| Q3 24 | 0.04× | — | ||
| Q2 24 | 0.12× | — | ||
| Q1 24 | 0.12× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $305.6M | $93.6M |
| Free Cash FlowOCF − Capex | — | $87.2M |
| FCF MarginFCF / Revenue | — | 25.7% |
| Capex IntensityCapex / Revenue | — | 1.9% |
| Cash ConversionOCF / Net Profit | 2.81× | 2.09× |
| TTM Free Cash FlowTrailing 4 quarters | — | $308.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $305.6M | $93.6M | ||
| Q3 25 | $91.7M | $111.3M | ||
| Q2 25 | $68.1M | $17.4M | ||
| Q1 25 | $78.5M | $116.6M | ||
| Q4 24 | $355.0M | $43.8M | ||
| Q3 24 | $89.9M | $48.8M | ||
| Q2 24 | $82.3M | $-27.4M | ||
| Q1 24 | $87.6M | — |
| Q4 25 | — | $87.2M | ||
| Q3 25 | — | $106.3M | ||
| Q2 25 | — | $13.6M | ||
| Q1 25 | — | $100.9M | ||
| Q4 24 | — | $35.2M | ||
| Q3 24 | — | $39.4M | ||
| Q2 24 | — | $-33.1M | ||
| Q1 24 | — | — |
| Q4 25 | — | 25.7% | ||
| Q3 25 | — | 32.5% | ||
| Q2 25 | — | 4.2% | ||
| Q1 25 | — | 30.5% | ||
| Q4 24 | — | 10.1% | ||
| Q3 24 | — | 11.4% | ||
| Q2 24 | — | -9.8% | ||
| Q1 24 | — | — |
| Q4 25 | — | 1.9% | ||
| Q3 25 | — | 1.5% | ||
| Q2 25 | — | 1.2% | ||
| Q1 25 | — | 4.7% | ||
| Q4 24 | — | 2.5% | ||
| Q3 24 | — | 2.7% | ||
| Q2 24 | — | 1.7% | ||
| Q1 24 | — | — |
| Q4 25 | 2.81× | 2.09× | ||
| Q3 25 | 1.28× | 2.88× | ||
| Q2 25 | 0.95× | 0.51× | ||
| Q1 25 | 1.56× | 2.01× | ||
| Q4 24 | 6.81× | 1.17× | ||
| Q3 24 | 1.62× | 1.44× | ||
| Q2 24 | 1.37× | -0.71× | ||
| Q1 24 | 1.50× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FIBK
Segment breakdown not available.
HAE
| Hospital | $143.5M | 42% |
| Plasma Productsand Services | $138.9M | 41% |
| Blood Center Productsand Services | $56.6M | 17% |
